Judiciary

Bipartisan Policy Center’s Anand Parekh: Rulings on USPSTF, mifepristone are ideological threats to evidence-based care
Conversation with The Cancer LetterJudiciary

Bipartisan Policy Center’s Anand Parekh: Rulings on USPSTF, mifepristone are ideological threats to evidence-based care

The United States has the worst health outcomes of any high-income nation—lagging behind on health status indicators including mortality, fertility, and morbidity—and recent rulings by Texas district judges against preventive services and mifepristone would widen that gap, experts say.